• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤中14q32/IGH易位与13号染色体异常之间的密切关系:11q13/CCND1和16q23/MAF的高发生率

Close relation between 14q32/IGH translocations and chromosome 13 abnormalities in multiple myeloma: a high incidence of 11q13/CCND1 and 16q23/MAF.

作者信息

Takimoto Madoka, Ogawa Kohei, Kato Yo, Saito Tasuku, Suzuki Takao, Irei Michiko, Shibuya Yasushi, Suzuki Yoshinori, Kato Masayuki, Inoue Yasuyuki, Takahashi Masatomo, Sugimori Hiroki, Miura Ikuo

机构信息

Department of Internal Medicine, Division of Hematology and Oncology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, 218-8511, Japan.

出版信息

Int J Hematol. 2008 Apr;87(3):260-5. doi: 10.1007/s12185-008-0039-x. Epub 2008 Feb 16.

DOI:10.1007/s12185-008-0039-x
PMID:18274833
Abstract

Many B-cell tumors have chromosomal translocations that result from failures of the immunoglobulin (Ig) gene during V(D)J recombination, somatic hypermutation (SHM), and class switch recombination (CSR). Nearly half of all multiple myeloma (MM) patients have 14q32/IGH translocations in CSR, including the five common translocations of 11q13/CCND1, 6p21/CCND3, 4p16/FGFR3, 16q23/MAF, and 20q11/MAFB. Although 14q32/IGH translocations are closely related to the biological features of MM, the most consistent and powerful prognostic factor has been reported to be the loss of all (monosomy 13/-13) or part of chromosome 13 (del(13)(q14)/13q-). Our fluorescence in situ hybridization (FISH) analysis method was designed to detect -13/13q- and 14q32/IGH rearrangements in 23 MM patients. FISH disclosed 14q32/IGH translocations in 10 of the 23 (43.5%) patients. The common translocation partners of 14q32/IGH were 11q13/CCND1 (five patients) and 16q23/MAF (four patients), followed in third place by 4p16/FGFR3 (one patient). Nine of the ten patients carrying 14q32/IGH translocations had -13/13q-. Abnormalities of chromosome 13 included -13 in seven (70%) and del(13)(q14) in two (20%). Our results suggest a significant correlation between the presence of 14q32/IGH translocations and chromosome 13 abnormalities (P = 0.0276) in MM patients.

摘要

许多B细胞肿瘤存在染色体易位,这是由于免疫球蛋白(Ig)基因在V(D)J重组、体细胞超突变(SHM)和类别转换重组(CSR)过程中出现故障所致。几乎一半的多发性骨髓瘤(MM)患者在CSR过程中存在14q32/IGH易位,包括11q13/CCND1、6p21/CCND3、4p16/FGFR3、16q23/MAF和20q11/MAFB这五种常见易位。尽管14q32/IGH易位与MM的生物学特征密切相关,但据报道,最一致且有力的预后因素是13号染色体全部缺失(13号染色体单体/-13)或部分缺失(13号染色体长臂14区缺失/del(13)(q14)/13q-)。我们的荧光原位杂交(FISH)分析方法旨在检测23例MM患者中的-13/13q-和14q32/IGH重排。FISH检测发现,23例患者中有10例(43.5%)存在14q32/IGH易位。14q32/IGH的常见易位伙伴是11q13/CCND1(5例患者)和16q23/MAF(4例患者),排在第三位的是4p16/FGFR3(1例患者)。携带14q32/IGH易位的10例患者中有9例存在-13/13q-。13号染色体异常包括7例(70%)的-13和2例(20%)的del(13)(q14)。我们的结果表明,MM患者中14q32/IGH易位的存在与13号染色体异常之间存在显著相关性(P = 0.0276)。

相似文献

1
Close relation between 14q32/IGH translocations and chromosome 13 abnormalities in multiple myeloma: a high incidence of 11q13/CCND1 and 16q23/MAF.多发性骨髓瘤中14q32/IGH易位与13号染色体异常之间的密切关系:11q13/CCND1和16q23/MAF的高发生率
Int J Hematol. 2008 Apr;87(3):260-5. doi: 10.1007/s12185-008-0039-x. Epub 2008 Feb 16.
2
Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.复发性免疫球蛋白基因易位可识别骨髓瘤的不同分子亚型。
Ann Oncol. 2000;11 Suppl 1:131-5.
3
Distinguishing primary and secondary translocations in multiple myeloma.鉴别多发性骨髓瘤中的原发性和继发性易位
DNA Repair (Amst). 2006 Sep 8;5(9-10):1225-33. doi: 10.1016/j.dnarep.2006.05.012. Epub 2006 Jul 10.
4
Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors.涉及免疫球蛋白或MYC基因座的继发性基因组重排在超二倍体和非超二倍体骨髓瘤肿瘤中的发生率相似。
Genes Chromosomes Cancer. 2008 Jul;47(7):573-90. doi: 10.1002/gcc.20563.
5
The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.通过原位杂交检测发现,免疫球蛋白重链基因在多发性骨髓瘤和浆细胞白血病中常参与染色体易位。
Blood. 1997 Jul 15;90(2):526-34.
6
High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.浆细胞恶性肿瘤患者中t(11;14)(q13;q32)和t(4;14)(p16;q32)易位的高发生率。
Cancer Res. 1998 Dec 15;58(24):5640-5.
7
In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.在多发性骨髓瘤中,14q32易位是非随机染色体融合,可驱动各自伙伴基因的高表达水平。
Genes Chromosomes Cancer. 2014 Jul;53(7):549-57. doi: 10.1002/gcc.22165. Epub 2014 Mar 17.
8
Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis.14q32易位和13q14缺失是系统性淀粉样变性常见的染色体异常。
Br J Haematol. 2002 May;117(2):427-35. doi: 10.1046/j.1365-2141.2002.03438.x.
9
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma.复发性免疫球蛋白重链(IgH)易位与非超二倍体变异型多发性骨髓瘤高度相关。
Blood. 2003 Oct 1;102(7):2562-7. doi: 10.1182/blood-2003-02-0493. Epub 2003 Jun 12.
10
High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization.荧光原位杂交显示,多发性骨髓瘤中涉及免疫球蛋白重链基因的隐匿性易位发生率很高。
Genes Chromosomes Cancer. 1999 Jan;24(1):9-15. doi: 10.1002/(sici)1098-2264(199901)24:1<9::aid-gcc2>3.0.co;2-k.

引用本文的文献

1
The TT Genotype of the Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma.该多态性的 TT 基因型与多发性骨髓瘤的不良预后相关。
Cells. 2023 Mar 28;12(7):1029. doi: 10.3390/cells12071029.
2
HDAC1 promotes the migration of human myeloma cells via regulation of the lncRNA/Slug axis.组蛋白去乙酰化酶 1 通过调节长链非编码 RNA/Slug 轴促进人骨髓瘤细胞的迁移。
Int J Mol Med. 2022 Jan;49(1). doi: 10.3892/ijmm.2021.5058. Epub 2021 Nov 5.

本文引用的文献

1
Multiple myeloma: a review of the epidemiologic literature.多发性骨髓瘤:流行病学文献综述
Int J Cancer. 2007;120 Suppl 12:40-61. doi: 10.1002/ijc.22718.
2
A comparison of allografting with autografting for newly diagnosed myeloma.新诊断骨髓瘤同种异体移植与自体移植的比较。
N Engl J Med. 2007 Mar 15;356(11):1110-20. doi: 10.1056/NEJMoa065464.
3
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome.多发性骨髓瘤的基因异常与生存:法语国家骨髓瘤研究组的经验
Blood. 2007 Apr 15;109(8):3489-95. doi: 10.1182/blood-2006-08-040410. Epub 2007 Jan 5.
4
International uniform response criteria for multiple myeloma.多发性骨髓瘤的国际统一反应标准。
Leukemia. 2006 Sep;20(9):1467-73. doi: 10.1038/sj.leu.2404284. Epub 2006 Jul 20.
5
Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: A study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression.免疫刺激寡核苷酸诱导的中期细胞遗传学检测发现80%的慢性淋巴细胞白血病患者存在染色体畸变:一项对132例慢性淋巴细胞白血病病例的研究,与荧光原位杂交、免疫球蛋白重链可变区基因(IgVH)状态及CD38表达的相关性分析
Blood. 2006 Nov 1;108(9):3152-60. doi: 10.1182/blood-2006-02-005322. Epub 2006 Jul 13.
6
Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma.通过传统细胞遗传学检测到的13号染色体缺失是骨髓瘤的一个关键预后因素。
Leukemia. 2006 Sep;20(9):1610-7. doi: 10.1038/sj.leu.2404304. Epub 2006 Jul 6.
7
Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma.高危初发多发性骨髓瘤患者自体干细胞移植后进行减剂量同种异体移植(IFM99 - 03试验)与序贯自体干细胞移植(IFM99 - 04试验)的前瞻性比较。
Blood. 2006 May 1;107(9):3474-80. doi: 10.1182/blood-2005-09-3869. Epub 2006 Jan 5.
8
Molecular pathogenesis and a consequent classification of multiple myeloma.多发性骨髓瘤的分子发病机制及相应分类
J Clin Oncol. 2005 Sep 10;23(26):6333-8. doi: 10.1200/JCO.2005.05.021.
9
Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma.骨髓瘤诊断时中期和/或间期细胞中检测到的染色体异常与患者生存率的关系。
Blood. 2005 Nov 15;106(10):3553-8. doi: 10.1182/blood-2005-05-1981. Epub 2005 Jul 19.
10
International staging system for multiple myeloma.多发性骨髓瘤国际分期系统
J Clin Oncol. 2005 May 20;23(15):3412-20. doi: 10.1200/JCO.2005.04.242. Epub 2005 Apr 4.